Raymond G. Hill
Board member
Orexo
Sweden
Biography
25 years of experience from pharmaceuticals industry, mostly in basic drug discovery research, initially for Parke Davis, followed by Smith Kline & French and then Merck. Executive Director of Pharmacology at the Neuroscience Research Centre 1990–2002, followed by a position as Executive Director, Licensing and External Research, Europe for Merck until 2008. Holds stock options entitiled to 8,746 shares, as of December 31 2016.
Research Interest
Business management
